Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 207

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 207

Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 208

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 208

Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 208

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 208

Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 214

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 214

Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 257

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 257

Notice: Undefined index: system in /WAS/WebDir/cdbio/_include/class.useragent.php on line 262

Notice: Trying to access array offset on value of type null in /WAS/WebDir/cdbio/_include/class.useragent.php on line 262
씨디바이오 | CDBIO

About Us

CEO Greetings

The Future of Molecular Diagnostics
for a healthy and happy life

According to the World Cancer Report Globocan 2020, recently published by the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), 2.21 million people worldwide (18,673 people domestically) have died of lung cancer in 2020. The reason for this high mortality rate from lung cancer is that it has no symptoms, thus is difficult to diagnose early. More than 50% of people who have been diagnosed with an abnormality in their lungs are already in stages 3 or 4, and only about 30% of cases are operable.

As such, the best way to overcome lung cancer is an early diagnosis. However, the efficiency of early diagnosis is low. For example, the diagnosis rate of lung cancer through chest X-ray, which is mainly used for conventional lung cancer screening, is only 54%, the positive prediction rate is only 7.5%, the diagnosis rate of low-dose chest CT is 61.9%, and the positive prediction rate is only 35.7%. It also takes a lot of time and money for patients to visit the hospital in person and get a diagnosis via X-rays and CTs. CD Bio is a biotech company established to improve the uncomfortable environment and accuracy of these early diagnoses.

Eun-Sang Kwon, CTO of CD Bio and professor at the Research and Analytical Center for Giant Molecules, Tohoku Univ., Japan, has developed the patented technology of "Molecule Sensor and Cancer Diagnosis System using Molecule Sensor" and has introduced a next generation cancer diagnostic system based on this.

The molecular diagnostic technology presented by CD Bio is a cutting-edge technology that can diagnose lung cancer early in a single breath (exhalation). With ultra-precise diagnostic technology that enables accuracy at the ppt (1/10¹²) level, while the accuracy of other cancer sensors and diagnosticians is mainly at the ppm (1/10⁶) to ppb (1/10⁹) level, it has now become possible for anyone to diagnose cancer easily and conveniently without worrying about cost, and to increase the cancer cure rate and survival probability with rapid treatment through early diagnosis.

With its unique molecular diagnostic technology based on molecular physics and electrochemistry, CD Bio will strive to make a revolutionary change to the medical market paradigm for everyone to live a healthy and happy life without fear of cancer. Thank you for visiting CDBIO.

Kyung-Jin Baek, CEO

CD BIO Overview

A Global Leader in Molecular
Diagnostics & Healthcare

Company CD Bio Co., Ltd.
CEO Kyung-Jin Baek
Address 3F Namsong Bldg, 12 Nonhyeon-ro 132-gil, Gangnam-gu, Seoul, Korea
Paid in Capital 3.6B (KRW)
Type of business Medical device manufacturing and wholesaling, software development
No of employees 20 people
URL https://www.cdbio.kr
Contact T+822-6925-5993
F+822-6925-5991
Vision & Strategy

Next Generation Diagnostic & Healthcare Platform
Using Molecular Physics & Electrochemistry

Mission

Contributing to the health and life extension of humankind
through innovative changes in the molecular diagnostic paradigm

Vision

The world's leading molecular diagnostic biotech company
using Li+@C60

Core Value
Innovative
Pursuing creative and unparalleled innovation led by the best researchers globally
Strategic
Diversifying the business and maximizing the enterprise value through strategic management
Mutuality
Building mutually beneficial networks for patients, medical staff, and researchers
Business Areas

Molecular Diagnostic & Healthcare Platform

Molecular
Healthcare
Platform

VOCs Biomarker

Research and development of biomarkers by detecting changes in the concentration of volatile organic compounds (VOCs) contained in exhaled breath

Molecular Diagnosis

Design of supramolecular sensors using Li+@C60 characteristics and development, manufacturing, and sales of various contactless in vitro diagnostic medical devices with high sensitivity and selectivity

  • VOCs Biosensing Kit and Bioscopic Analyzer for Hospitals
  • VOCs Biosensing Kit and Bioscopic Analyzer for Individuals
  • Various cancer and disease diagnosis systems
Molecular Big Data

Real-time monitoring of disease status and progress based on VOC data diagnosed through molecular sensors

  • Completion of big data that systematically builds molecular diagnostic data and personal medical information (e.g., EMR, PGHR) of users (patients)
Tailored Healthcare Service

Establishment of a hyper-personalized healthcare platform using artificial intelligence based on the constructed set of big data

  • Cloud-based real-time remote diagnosis and analysis service
  • Development of molecular synthetic therapeutics and drug delivery systems
  • Personalized health care service

CD Bio Certification

[ Corporate research institute certificate ]
[ Venture business confirmation ]
[ In vitro diagnostic medical device manufacturing license ]
[ FDA registration certificate ]
[ Certificate of medical device sales business ]

CD Bio Organization

CD Bio Partner

CD Bio Location